ask="N/A"
ask_size="N/A"
average_daily_volume="40150"
bid="14.14"
bid_size="400"
book_value="5.83"
change="-0.56"
change_from_200_day_moving_average="-4.66"
change_from_50_day_moving_average="-2.95"
change_from_52_week_high="-12.19"
change_From_52_week_low="4.15"
change_in_percent="-3.80%"
close="14.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="7054000"
high="14.86"
high_52_weeks="26.36"
last_trade_date="3/2/2017"
last_trade_price="14.17"
last_trade_size="874"
last_trade_time="4:00pm"
low="14.02"
low_52_weeks="10.02"
market_capitalization="236.84M"
moving_average_200_day="18.83"
moving_average_50_day="17.12"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="14.74"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-24.74%"
percent_change_from_50_day_moving_average="-17.22%"
percent_change_from_52_week_high="-46.24%"
percent_change_from_52_week_low="+41.42%"
previous_close="14.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.53"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="7.43"
stock_exchange="NGM"
symbol="PTGX"
volume="28520"
weeks_range_52="10.02 - 26.36"
